Dagoz-M Tablet ER
Marketer
Bio Schutz Pharmaceuticals Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Dagoz-M Tablet ER
Dagoz-M Extended-Release tablets combine two medications for managing type 2 diabetes. This dual-action therapy helps regulate elevated blood glucose, thereby lowering the risk of severe diabetic complications and contributing to heart health protection. Dagoz-M ER can be administered with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician and should not be discontinued without their consultation; abrupt cessation may elevate blood sugar, potentially leading to serious consequences such as renal impairment or vision loss. This medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Frequently reported side effects include pharyngitis, rhinitis, nasal congestion, cephalgia, nausea, emesis, and diarrhea. Adequate hydration is recommended to minimize dehydration. Genital fungal infections are a possibility; meticulous hygiene can mitigate this risk. Prior to commencing treatment, disclose any kidney or liver dysfunction, urinary tract infections, or diuretic use to your physician. Pregnant or lactating individuals should seek medical counsel before use. Limiting alcohol consumption is advised to reduce the likelihood of adverse reactions. Regular blood glucose monitoring is crucial during treatment.
Primary Ingredients of Dagoz-M Tablet ER
The information is unavailable.
Uses of Dagoz-M Tablet ER
Managing type 2 diabetes
Major Benefits of Dagoz-M Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dagoz-M Extended-Release Tablets. Ingest the tablets whole; do not crush, chew, or divide them. Administer Dagoz-M ER with a meal.
Common Side effects of Dagoz-M Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dagoz-M Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dagoz-M Extended-Release Tablets. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication with food.
How Dagoz-M Tablet ER works:
Dagoz-M Extended-Release tablets combine dapagliflozin and metformin to manage type 2 diabetes. Dapagliflozin eliminates excess glucose via urinary excretion, while metformin reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. This dual action optimizes blood glucose regulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Dagoz-M Tablet ER ingestion is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Dagoz-M tablet might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dagoz-M tablets pose a likely risk during lactation. Preliminary data from human studies indicate potential transfer to breast milk, potentially endangering the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Extended-release Dagoz-M tablets require careful administration in individuals with impaired renal function. Dosage modification of Dagoz-M extended-release tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Extended-release Dagoz-M tablets require careful administration for individuals with hepatic impairment. Dosage modification of Dagoz-M extended-release tablets may be necessary. Physician consultation is recommended.
What if you forget to take Dagoz-M Tablet ER :
Should you forget a Dagoz-M Extended Release tablet, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Dagoz-M Tablet ER
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Diabetes medication |



